Bins, Sander
Basak, Edwin A.
el Bouazzaoui, Samira
Koolen, Stijn L. W.
Oomen – de Hoop, E.
van der Leest, Cor H.
van der Veldt, Astrid A. M.
Sleijfer, Stefan
Debets, Reno
van Schaik, Ron H. N.
Aerts, Joachim G. J. V.
Mathijssen, Ron H. J.
Article History
Received: 3 January 2018
Revised: 9 March 2018
Accepted: 13 March 2018
First Online: 26 April 2018
Competing interests
: Van der Leest received personal fees from BMS. Van der Veldt is a member of an advisory board at BMS. Aerts is a member of an advisory board at BMS and has patents pending for analysis of biomarkers for immunotherapy. Mathijssen has patents pending for analysis of biomarkers for immunotherapy. The remaining authors declare no competing interests.
: The study was approved by the local ethics board of the Erasmus Medical Center study as number MEC 02–1002. The study was performed in accordance with the Declaration of Helsinki.
: Data supporting the results are archived in the Erasmus Medical Center.